Profile
PSTV VRTX ALNY REGN ARGX SGEN
Company Name Plus Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $27.95M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.02K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Marc H. Hedrick Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
PSTV VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 4 1 4 4 3
Quant Rating Strong Sell Buy Strong Sell Buy Buy Neutral
Trading
PSTV VRTX ALNY REGN ARGX SGEN
Last Close $0.4129 $393.21 $461.14 $572.59 $756.83 $228.74
High 52 $1.85 $516.74 $482.13 $1153.08 $768 $228.74
Low 52 $0.18 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -77.68 % -23.91 % -4.35 % -50.34 % -1.45 % 0 %
Price vs. 52 Week Low 129.39 % 7.28 % 105.33 % 18.57 % 45.61 % 0 %
Total Return
PSTV VRTX ALNY REGN ARGX SGEN
1 Month Return -34.24 % 0.11 % 2.72 % -1.35 % 15.75 % 0 %
3 Month Return 36.63 % -12.8 % 49.34 % 9.55 % 37.3 % 0 %
6 Month Return -39.17 % -22.1 % 90.74 % -14.14 % 25.1 % 0 %
9 Month Return -64.71 % -16 % 89 % -21.01 % 19.63 % 0 %
YTD Return -64.1 % -2.36 % 95.97 % -19.62 % 23.06 % 0 %
1 Year Return -72.66 % -19.66 % 70.56 % -50.34 % 40.69 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PSTV VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -481.74 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
PSTV VRTX ALNY REGN ARGX SGEN
Asset Growth -41.75 % -0.87 %
Gross Profit Growth 204.08 % 10.25 %
Revenue Growth 18.54 % 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year -98.84 % 163.93 %
Revenue 10 Year 833.1 % 1632.15 %
EBIT Growth 30.53 % -93.69 %
Net Income Growth 2.54 % -114.8 %
Net Income 3 Yeari Growth Per Share 88.26 % -122.89 %
Net Income 5 Yeari Growth Per Share 98.34 % -145.38 %
Net Income 10 Yeari Growth Per Share -322.78 % 33.84 %
Operating Income Growth -10.31 % -106.08 %
Operating Cash Flow Growth (CFG) 17.87 % -113.93 %
Operating 3 Year CFG 87.56 % -118.65 %
Operating 5 Year CFG 97.52 % -131.3 %
Operating 10 Year CFG -323.6 % 12.43 %
EPS Growth 54.01 % -114.8 %
EPS Diluted Growth 44.81 % -114.97 %
Book Value Per Share -214.03 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -110.01 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -110.72 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -1810.54 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -19.47 % 116.42 %
Free Cash Flow Growth 17.76 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
PSTV VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 86.25 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -183.84 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM 219.14 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -421 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 148.96 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -240.23 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -56203.33 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 5.21 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.1 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 1672.01 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 51.37 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.35 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.35 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 14.22 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -317.11 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.21 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -56203.33 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -1.65 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -1.33 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -1.33 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
PSTV VRTX ALNY REGN ARGX SGEN
Revenue $0.01B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 85.37% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -2.34 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
PSTV VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $-0.01B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
PSTV VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.34
AARD Aardvark Therapeutics, Inc. Common Stock 10.24
ABCL AbCellera Biologics Inc. 4.765
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.67
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.22
ABPWW 0.0316
ABSI Absci Corporation 2.705
ABUS Arbutus Biopharma Corporation 4.395
ABVC ABVC BioPharma, Inc. 2.83
ABVX Abivax SA American Depositary Shares 82.28
ACAD ACADIA Pharmaceuticals Inc. 23.96
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8085
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.085
ACIU AC Immune SA 2.53
ETFs With Exposure to PSTV
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.48
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 144.05
VXF Vanguard Extended Market Index Fund 0.00005 209.17
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00006 158.85
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00006 158.86
VEMPX Vanguard Extended Market Index InstlPlus 0.00006 392.02
Unlock